Michael Celano Larimar Therapeutics, Inc. (LRMR) insider trading activity

LRMR Quotes by TradingView

Michael Celano is Chief Financial Officer of Larimar Therapeutics, Inc.. Currently has a direct ownership of 215,785 shares of LRMR, which is worth approximately $729,353. The most recent transaction as insider was on Jan 26, 2026, when has been sold 37,604 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 216K
21.1% 3M change
21.1% 12M change
Total Value Held $729,353

Michael Celano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2026
BUY
Grant, award, or other acquisition
-
37,604 Added 14.84%
215,785 Common Stock
Jan 22 2025
BUY
Grant, award, or other acquisition
-
34,185 Added 16.1%
178,181 Common Stock
Jan 17 2024
BUY
Grant, award, or other acquisition
-
31,250 Added 17.83%
143,996 Common Stock
May 17 2023
BUY
Open market or private purchase
$18,650 $3.73 p/Share
5,000 Added 4.25%
112,746 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
76,000 Added 41.36%
107,746 Common Stock
Sep 16 2022
BUY
Open market or private purchase
$100,000 $3.15 p/Share
31,746 Added 50.0%
31,746 Common Stock

Also insider at

OSUR
ORASURE TECHNOLOGIES INC Healthcare
Director
MC

Michael Celano

Chief Financial Officer
Bethlehem, PA

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LRMR